Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2010-06-24

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10545-010-9148-9PMID 20574716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of novel mutations in the SLC25A15 gene in hyperornithinemia‐hyperammonemia‐homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study

  2009influential reference
• Phenotypic variability among patients with hyperornithinaemia–hyperammonaemia–homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15

  2008cited by this paper
• Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome (HHH) Presenting With Acute Fulminant Hepatic Failure

  2008influential reference
• Clinical and Functional Characterization of a Human ORNT1 Mutation (T32R) in the Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome

  2006cited by this paper
• HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation

  2006cited by this paper
• Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.

  2004cited by this paper
• Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.

  2003cited by this paper
• Diagnosis of Japanese patients with HHH syndrome by molecular genetic analysis: a common mutation, R179X

  2001cited by this paper
• Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Three novel mutations (G27E, insAAC, R179X) in the ORNT1 gene of Japanese patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome

  2000cited by this paper
• Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter

  1999influential reference
• Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry.

  1997cited by this paper
• Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.

  1997cited by this paper
• A mouse model of gyrate atrophy of the choroid and retina. Early retinal pigment epithelium damage and progressive retinal degeneration.

  1996cited by this paper
• Prenatal exclusion of the hhh syndrome

  1995cited by this paper
• Hyperornithinemia, hyperammonemia, homocitrullinuria (HHH) syndrome: presentation as acute liver disease with coagulopathy.

  1992cited by this paper
• Neonatal form of the hyperornithinaemia, hyperammonaemia, and homocitrullinuria (HHH) syndrome and prenatal diagnosis

  1992cited by this paper
• Hyperammonemia-hyperornithinemia-homocitrullinuria syndrome: neurologic, ophthalmologic, and neuropsychologic examination of six patients.

  1992cited by this paper
• Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.

  1990cited by this paper
• Knots in a string : an introduction to native studies in Canada

  1989cited by this paper
• Population Genetics

  1956cited by this paper

• Newborn screening for neuro-metabolic disorders: Strategies, clinical benefits, and prerequisites for program expansion.

  2025cites this paper
• Review: Utility of mass spectrometry in rare disease research and diagnosis

  2025cites this paper
• Hyperornithinemia–Hyperammonemia–Homocitrullinuria Syndrome in Vietnamese Patients

  2024cites this paper
• Neonatal Urine Screening Program in the Province of Quebec: Technological Upgrade from Thin Layer Chromatography to Tandem Mass Spectrometry

  2021cites this paper
• Urea cycle disorders

  2020cites this paper
• JIMD Reports, Volume 44

  2019cites this paper
• A neonate with hyperornithinemia-hyperammonemiahomocitrullinuria syndrome from a consanguineous Pakistani family

  2019cites this paper
• The Association between SLC25A15 Gene Polymorphisms and Hyperornithinemia-hyperammonemia-homocitrullinuria Syndrome: Using In Silico Analysis

  2019cites this paper
• Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision

  2019cites this paper
• Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome Causing Severe Neonatal Hyperammonemia.

  2019cites this paper
• Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing

  2018cites this paper
• Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis

  2018cites this paper
• Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease‐causing variants

  2017cites this paper
• Chapter 6 – Newborn screening

  2017cites this paper
• Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy.

  2016cites this paper
• Biomarkers-Directed Strategies to Treat Autism

  2016cites this paper
• Ornithine and Homocitrulline Impair Mitochondrial Function, Decrease Antioxidant Defenses and Induce Cell Death in Menadione-Stressed Rat Cortical Astrocytes: Potential Mechanisms of Neurological Dysfunction in HHH Syndrome

  2016cites this paper
• Disorders of Ornithine and Proline Metabolism

  2016cites this paper
• Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001–2013

  2016cites this paper
• The hyperornithinemia–hyperammonemia-homocitrullinuria syndrome

  2015cites this paper
• Creatine biosynthesis and transport in health and disease.

  2015cites this paper
• Title Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome : a treatable genetic liver disease warranting urgent diagnosis

  2014cites this paper
• Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

  2014cites this paper
• Challenges of experimental gene therapy for urea cycle disorders

  2014cites this paper
• High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.

  2014cites this paper
• Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome: a treatable genetic liver disease warranting urgent diagnosis.

  2014cites this paper
• Incidence and carrier frequency of Sandhoff disease in Saskatchewan determined using a novel substrate with detection by tandem mass spectrometry and molecular genetic analysis.

  2014cites this paper
• Expanded newborn screening for inborn errors of metabolism: overview and outcomes.

  2012cites this paper
• Newborn Screening for Inborn Errors of Metabolism

  2012cites this paper
• Suggested guidelines for the diagnosis and management of urea cycle disorders

  2012cites this paper
• LC-MS/MS progress in newborn screening.

  2011cites this paper
• The role of amino acid transporters in inherited and acquired diseases.

  2011cites this paper